$AXON earnings report

Axon reports record Q3 2026 revenue of $909 million, up 28% year over year. AlphAI read Axon Enterprise's Q3 FY2026 filing as mixed. 2 quarters are on record below.

Q3 FY2026

AlphAI · Earnings readAXON · Q3 2026 · ended 30 SEP 2026

Axon reports record Q3 2026 revenue of $909 million, up 28% year over year

→Mixed quarter

Revenue, Software & Services growth, bookings and Adjusted EBITDA were strong, but the full-year revenue outlook was reduced following the removal of approximately $130 million of Federal Dedrone deployments, gross margins declined and free cash flow was an outflow.

Revenue
$909M
28% y/y
Software & Services
$437M
43.2% y/y · 9.9% q/q
Gross margin · GAAP
56.7%
EPS · non-GAAP
$1.72
Q4 2026 and full year 2026 outlook
Q4 2026: $990 million to $1.01 billion; full year 2026: approximately $3.61 billion to $3.63 billion, representing approximately 30% annual growth

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Q3 2026 net salesGAAP$908.6M–28%
Q3 2026 net sales from productsGAAP$471.5M––
Q3 2026 net sales from servicesGAAP$437.0M––
Q3 2026 gross marginGAAP56.7%––
Q3 2026 adjusted gross marginnon-GAAP59.2%––
Q3 2026 gross marginGAAP$515.0M––
Q3 2026 operating expensesGAAP$472.9M––
Q3 2026 selling, general and administrative expenseGAAP$280.5M––
Q3 2026 research and development expenseGAAP$192.4M––
Q3 2026 income from operationsGAAP$42.08M––
Q3 2026 net incomeGAAP$57.01M––
Q3 2026 net income marginGAAP6.3%––
Q3 2026 diluted earnings per shareGAAP$0.68––
Q3 2026 non-GAAP net incomenon-GAAP$143.5M––
Q3 2026 non-GAAP net income marginnon-GAAP15.8%––
Q3 2026 non-GAAP diluted earnings per sharenon-GAAP$1.72––
Q3 2026 Adjusted EBITDAnon-GAAP$235.7M–33%
Q3 2026 Adjusted EBITDA marginnon-GAAP25.9%––
Q3 2026 operating cash flowGAAP$19.69M––
Q3 2026 free cash flownon-GAAP−$18.90M––
Q3 2026 capital expendituresGAAP$38.59M––
Q3 2026 annual recurring revenueother$1.75B–40%
Q3 2026 net revenue retentionother126%––
Q3 2026 future contracted bookingsother$15.8B–39%
Nine months ended 30 SEP 2026 net salesGAAP$2.62B––
Nine months ended 30 SEP 2026 gross marginGAAP$1.54B––
Nine months ended 30 SEP 2026 income from operationsGAAP$118.1M––
Nine months ended 30 SEP 2026 net incomeGAAP$255.7M––
Nine months ended 30 SEP 2026 diluted earnings per shareGAAP$3.08––
Nine months ended 30 SEP 2026 Adjusted EBITDAnon-GAAP$679.3M––
Nine months ended 30 SEP 2026 free cash flownon-GAAP−$74.52M––

Segments

SegmentRevenueq/qy/y
Software & ServicesGrowth in users and increasing adoption of premium solutions by existing customers, including AI, real-time operations, Axon Records and Axon 911.$437.0M9.9%43.2%
Connected DevicesLed by Dedrone and continued adoption of Axon Body 4, partially offset by lower legacy TASER volume and the timing of an approximately $30 million Federal Dedrone deployment.$471.5M(6.9)%16.3%
TASERIncludes TASER devices, cartridges and related extended warranties.$233.0M––
Personal SensorsPrimarily includes body cameras and accessories, signal sidearm, and related extended warranties.$113.5M––
Platform SolutionsGrowth was led by Platform Solutions; the category primarily includes fleet in-car video, interview room, fixed cameras, drones and counter-drone equipment, virtual reality training hardware, and related extended warranties.$125.0M–106%

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Q4 2026 and full year 2026 outlook

  • RevenueQ4 2026: $990 million to $1.01 billion; full year 2026: approximately $3.61 billion to $3.63 billion, representing approximately 30% annual growth
  • NoteQ4 2026 Adjusted EBITDA: $245 million to $250 million
  • NoteFull-year 2026 Adjusted EBITDA: $924 million to $929 million
  • NoteFull-year 2026 Adjusted EBITDA margin: approximately 25.6%
  • NoteFull-year 2026 free cash flow: $350 million to $400 million
  • NoteFull-year 2026 stock-based compensation expense: approximately $570 million to $600 million
  • Note2026 CapEx: $130 million to $150 million
  • NoteInventory strategy expected to utilize $225 million in cash for the full year

What drove it

  • Software & Services revenue grew 43% year over year, driven by growth in users and increasing adoption of premium solutions by existing customers.
  • Newer software offerings, including real-time operations, Axon Records, Axon AI, Axon 911 and Dedrone software, collectively reached an annual revenue run rate of nearly $500 million.
  • AI annual recurring revenue surpassed $100 million, and AI bookings were up over 50% year to date.
  • Platform Solutions revenue increased 106% year over year to $125 million.
  • New five-year bookings were up 25% year to date.
  • Future contracted bookings grew 39% year over year to $15.8 billion.
  • Axon announced an additional $1.2 billion investment in Skydio, increasing fully diluted ownership to 37%, alongside an exclusive public safety distribution partnership in the U.S. and Canada.

Concerns

  • The full-year revenue outlook excludes approximately $130 million from three Federal Dedrone deployments no longer expected in 2026, including approximately $30 million previously expected in Q3 and $100 million previously expected in Q4.
  • Total company gross margin declined to 56.7% from 60.1%, while adjusted gross margin declined to 59.2% from 62.7%, primarily due to counter-drone equipment mix, higher memory costs and scaling new product categories.
  • Connected Devices gross margin declined to 43.0% from 49.9%; management cited increased counter-drone equipment mix and higher memory costs.
  • Free cash flow was an outflow of $19 million, primarily reflecting approximately $100 million of strategic inventory investment.
  • The company reported a net debt position of $1.2 billion as of September 30, 2026.

What to watch

  • Timing and fulfillment of the three Federal Dedrone deployments totaling approximately $130 million excluded from the 2026 outlook.
  • Whether Q4 revenue reaches the $990 million to $1.01 billion guidance range.
  • Whether Software & Services maintains its 43% year-over-year growth rate and whether newer offerings continue to scale.
  • Gross-margin effects from counter-drone equipment mix, memory costs and new product-category scaling.
  • The pace at which the approximately $225 million full-year inventory investment moderates after the first quarter of 2027.
  • Closing timing and financial impact of the $1.2 billion Skydio investment and ramp of Axon's exclusive distribution relationship.

Balance sheet and cash flow

  • As of September 30, 2026, cash, cash equivalents and short-term investments were $1.7 billion.
  • As of September 30, 2026, outstanding convertible and senior notes were $2.9 billion.
  • As of September 30, 2026, Axon had a net debt position of $1.2 billion, up $182 million sequentially.
  • Cash and cash equivalents were $1,458,817 (in thousands) at 30 SEP 2026, compared with $1,201,147 (in thousands) at 31 DEC 2025.
  • Inventory was $579,225 (in thousands) at 30 SEP 2026, compared with $341,811 (in thousands) at 31 DEC 2025.
  • Q3 operating cash flow was $19,687 (in thousands), including approximately $100 million of cash used for strategic inventory investment.
  • Q3 free cash flow was an outflow of $19 million, compared to an inflow of $33 million in the prior-year period.
  • Long-term notes payable, principal amount, were $(2,900,000) (in thousands) at 30 SEP 2026.

Analysis

Axon delivered record Q3 revenue of $909 million, up 28% year over year, with the revenue mix continuing to shift toward software. Software & Services grew 43% to $437 million, outpacing Connected Devices, which grew 16% to $472 million. Management attributed software growth to user growth and adoption of premium solutions, while newer offerings including AI, real-time operations, Axon Records, Axon 911 and Dedrone software collectively reached an annual revenue run rate of nearly $500 million. Annual recurring revenue rose 40% to $1.8 billion, net revenue retention was 126%, and future contracted bookings rose 39% to $15.8 billion.

Profitability improved substantially from the prior-year loss. GAAP operating income was $42 million versus a $2 million loss from operations, GAAP net income was $57 million versus a $2 million net loss, and Adjusted EBITDA increased 33% to $236 million. However, gross-margin pressure was material. Total gross margin declined to 56.7% from 60.1% and adjusted gross margin declined to 59.2% from 62.7%. Connected Devices was the principal pressure point, with gross margin falling to 43.0% from 49.9%, reflecting counter-drone equipment mix and higher memory costs. Software & Services gross margin also declined to 71.4% from 73.8% as new product offerings and professional services scaled.

Connected Devices revenue declined sequentially to $472 million from $507 million. Management identified normal third-quarter seasonality and the delayed timing of an approximately $30 million Federal Dedrone deployment as factors. Platform Solutions nevertheless grew 106% year over year to $125 million, while lower legacy TASER volume partially offset growth from Dedrone and Axon Body 4. The company also announced a $1.2 billion investment in Skydio that raises its fully diluted ownership stake to 37%, plus an exclusive U.S. and Canada public-safety distribution partnership. Skydio channel revenue will be recognized on a net basis in Software & Services.

Cash conversion was weak in the quarter because of inventory investment. Operating cash flow was $20 million, down from $60 million, and free cash flow was an outflow of $19 million versus an inflow of $33 million. The company said approximately $100 million of cash was used for strategic inventory investment during the quarter. Cash, cash equivalents and short-term investments were $1.7 billion, while convertible and senior notes were $2.9 billion, resulting in a net debt position of $1.2 billion.

The outlook was reduced because Axon no longer expects three large Federal Dedrone deployments totaling approximately $130 million to occur in 2026. Q4 revenue guidance is $990 million to $1.01 billion, implying full-year revenue of approximately $3.61 billion to $3.63 billion and approximately 30% growth, versus prior full-year growth guidance of 32% to 34%. Full-year Adjusted EBITDA guidance is $924 million to $929 million and the approximately 25.6% margin is 10 basis points above prior margin guidance of 25.5%. Full-year free-cash-flow guidance of $350 million to $400 million is below the prior $450 million target, while stock-based compensation and CapEx guidance were both reduced.

Not in the filing

stated, not guessed
  • Prior-release outlook was not provided; therefore, no actual-versus-prior-guidance comparisons are included.
  • No share repurchases were reported.
  • No dividends were reported.
  • Q4 2026 gross margin guidance was not provided.
  • Q4 2026 operating expense guidance was not provided.
  • Q4 2026 tax rate guidance was not provided.
  • No named company executive quote was provided in the filing text.
  • Year-over-year and sequential percentage changes were not separately printed for all income-statement line items and product-category revenue lines.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Q2 FY2026

AlphAI · Earnings readAXON · Q2 2026 · ended June 30, 2026

Axon reports Q2 2026 revenue of $904 million, up 35% year over year

✓Strong quarter

Revenue grew 35% year over year, both primary segments grew above 35%, forward contracted bookings grew 41% to $15.1 billion, and the company raised its 2026 revenue growth outlook to 32% to 34% while maintaining its Adjusted EBITDA margin outlook.

Revenue
126%
Software & Services
$398M
36% y/y
Gross margin · GAAP
60.4%
flat year over year y/y · up 130 basis points sequentially q/q
EPS · non-GAAP
$1.88
2026 outlook
2026 revenue growth of 32% to 34%

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Quarterly revenueGAAP$904M–35%
Annual recurring revenueother$1.6B–39%
Net revenue retentionother126%––
Future contracted bookingsother$15.1B–41%
New contract bookings on a five-year normalized basisothermore than 30%–more than 30%
Total company gross marginGAAP60.4%up 130 basis points sequentiallyflat year over year
Adjusted gross marginnon-GAAP62.9%increased 130 basis points sequentiallydecreased 40 basis points year over year
COGSGAAP$358 million, or 39.6% of revenue––
Stock-based compensation expense in COGSGAAP$11M––
SG&A expenseGAAP$291 million, or 32.2% of revenue––
Stock-based compensation expense in SG&AGAAP$71M––
R&D expenseGAAP$209 million, or 23.1% of revenue––
Stock-based compensation expense in R&DGAAP$62M––
Operating incomeGAAP$47M–increased $48 million year over year
Net incomeGAAP$29M––
Net income marginGAAP3.3%––
Diluted earnings per shareGAAP$0.36 per diluted share––
Non-GAAP net incomenon-GAAP$155M––
Non-GAAP net income marginnon-GAAP17.2%––
Non-GAAP diluted earnings per sharenon-GAAP$1.88 per diluted share––
Adjusted EBITDAnon-GAAP$242M–increased over 40% year over year
Adjusted EBITDA marginnon-GAAP26.8%––
Operating cash flowGAAP$20M––
Free cash flowotherfree cash outflow of $1 million––
Cash received from tariff refundsother$47M––
Cash, cash equivalents and short-term investmentsGAAP$685M––
Outstanding senior notes principal amountGAAP$1.8B––
Net debt positionGAAP$1.1Bup $46 million sequentially–
Dedrone revenueothersurpasses $100 million––

Segments

SegmentRevenueq/qy/y
Software & Servicesnew users and increased adoption of premium software offerings, including the AI Era Plan$398M–36%
Connected DevicesDedrone, TASER 10 and Axon Body 4$507M–35%
Platform SolutionsDedrone revenue surpasses $100 million$150M–123%

2026 outlook

  • Revenue2026 revenue growth of 32% to 34%
  • NoteAdjusted EBITDA margin of approximately 25.5%

What drove it

  • Demand remained robust among both new and existing customers.
  • Software & Services growth was driven by new users and increased adoption of premium software offerings, including the AI Era Plan.
  • Connected Devices growth was driven by Dedrone, TASER 10 and Axon Body 4.
  • Future contracted bookings grew 41% year over year to $15.1 billion.
  • International and enterprise bookings each approximately tripled year over year.
  • Adjusted EBITDA growth was driven by higher revenue and global tariff refunds.

Concerns

  • Gross margin reflected a higher mix of professional services revenue and scaling new product offerings, partially offset by global tariff refunds received in the quarter.
  • Net income and non-GAAP net income declined year over year, primarily reflecting a large tax benefit recognized in the prior year.
  • Operating income was partially offset by increased investment to drive future growth.
  • Cash flow was partially offset by continued inventory investment to support customer demand and timing of customer billing and collections.
  • The company reported a net debt position of $1.1 billion.

What to watch

  • Execution against 2026 revenue growth of 32% to 34%.
  • Maintenance of an Adjusted EBITDA margin of approximately 25.5%.
  • Growth in future contracted bookings, including bookings reported on a five-year normalized basis.
  • Adoption of premium software offerings, including the AI Era Plan.
  • Demand for Dedrone, TASER 10 and Axon Body 4.
  • The effect of professional services mix, new-product scaling and tariff refunds on gross margin.
  • Inventory investment, customer billing and collections as drivers of operating cash flow and free cash flow.

Balance sheet and cash flow

  • Operating cash flow improved to $20 million from an outflow of $92 million in the prior year.
  • Free cash outflow of $1 million.
  • As of June 30, 2026, Axon had $685 million in cash, cash equivalents and short-term investments.
  • Outstanding senior notes had a principal amount of $1.8 billion.
  • Net debt position was $1.1 billion, up $46 million sequentially.
  • Total cash received from tariff refunds was $47 million.

Analysis

Axon reported Q2 2026 revenue of $904 million, up 35% year over year, extending its stated run of 10 consecutive quarters of revenue growth above 30%. Growth was broad-based, with Software & Services revenue up 36% to $398 million and Connected Devices revenue up 35% to $507 million. Annual recurring revenue grew 39% to $1.6 billion and net revenue retention reached 126%, pointing to continued expansion among existing customers alongside new-user additions.

Forward demand indicators were also strong. Future contracted bookings grew 41% year over year to $15.1 billion, while new contract bookings on a five-year normalized basis grew more than 30% year over year. The company cited two nine-figure agreements with major U.S. cities, two eight-figure agreements with major state corrections customers, and its first full-scope Axon 911 customer agreement. International and enterprise bookings each approximately tripled year over year.

Profitability was mixed across the income statement. Total company gross margin was flat year over year at 60.4% and improved 130 basis points sequentially, while adjusted gross margin of 62.9% decreased 40 basis points year over year and increased 130 basis points sequentially. Operating income increased $48 million year over year to $47 million. Net income declined to $29 million from $36 million, and non-GAAP net income declined to $155 million from $179 million, primarily because of a large tax benefit recognized in the prior year. Adjusted EBITDA increased over 40% year over year to $242 million, producing a 26.8% margin.

Cash conversion improved materially, with operating cash flow of $20 million compared with an outflow of $92 million in the prior year and free cash outflow of $1 million. The company attributed the improvement primarily to higher EBITDA, partly offset by inventory investment and customer billing and collections timing. Axon ended June 30, 2026 with $685 million in cash, cash equivalents and short-term investments, $1.8 billion of outstanding senior notes principal, and a $1.1 billion net debt position.

Management raised its 2026 revenue growth outlook to 32% to 34% from 30% to 32% previously and maintained its approximately 25.5% Adjusted EBITDA margin outlook. The outlook increase follows the reported revenue, bookings and recurring-revenue growth, while the unchanged margin outlook places attention on investment levels, professional-services mix, scaling new products and the contribution from tariff refunds.

Not in the filing

stated, not guessed
  • Exact prior-year quarterly revenue amount.
  • Exact prior-quarter revenue amount.
  • Exact prior-year and prior-quarter amounts for Software & Services revenue.
  • Exact prior-year and prior-quarter amounts for Connected Devices revenue.
  • Exact prior-year and prior-quarter amounts for Platform Solutions revenue.
  • Exact prior-year and prior-quarter total company gross margin.
  • Exact prior-year and prior-quarter adjusted gross margin.
  • Exact prior-year operating income amount.
  • Exact prior-year GAAP diluted earnings per share.
  • Exact year-over-year change for GAAP net income, GAAP net income margin, GAAP diluted earnings per share, non-GAAP net income, non-GAAP net income margin and non-GAAP diluted earnings per share.
  • Exact prior-year Adjusted EBITDA amount.
  • Exact prior-year and prior-quarter Adjusted EBITDA margin.
  • Exact prior-year free cash flow amount.
  • Tax rate.
  • Capital return information, including share repurchases and dividends.
  • Full-year 2026 guidance for gross margin, operating expenses and tax rate.
  • Prior outlook section from the previous release for formal actual-versus-prior-guidance comparison.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about AXON earnings dates

When is Axon Enterprise's next earnings date?
AlphAI has no date for AXON yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.